Dr. Rupesh R. Kotecha, M.D.
Radiation Oncology (Radiation Oncology Physician)
- Medicare participating
At a glance
- Medical school
- Michigan State University College of Human Medicine (2012)
- Years since graduation
- 14
- In the NPI registry since
- 2012
- Medicare patients seen, 2024
- 285
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2012Medical school: Michigan State University College of Human Medicine
- 2012Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Radiation Oncology Physician primary
FL license ME131122
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Baptist Hospital of Miami Miami, FL
- South Miami Hospital Miami, FL
- Mariners Hospital Tavernier, FL
Medical groups
- Baptist Health Medical Group Oncology LLC (204 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 285
- Services billed
- 2,440
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Calculation of radiation therapy dose | 969 | 98 |
| Ct guidance for insertion of radiation therapy fields | 358 | 64 |
| Design and construction of complex radiation treatment device | 350 | 101 |
| Radiation treatment management, 5 treatment sessions | 157 | 56 |
| Complex radiation therapy planning | 136 | 106 |
| Established patient office or other outpatient visit, 40-54 minutes | 119 | 85 |
| Established patient office or other outpatient visit, 20-29 minutes | 97 | 75 |
| High precision radiation therapy planning | 91 | 57 |
| Design and construction of radiation treatment device for high precision radiation therapy | 78 | 45 |
| 3d radiation therapy planning | 70 | 46 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 5 companies reported 47 payments worth $54,952 in total to this clinician.
| Novocure Inc. | $30,613 |
|---|---|
| Elekta, Inc. | $12,737 |
| Gt Medical Technologies, Inc | $6,743 |
| Servier Pharmaceuticals LLC | $4,772 |
| Brainlab, Inc. | $86.69 |
| Consulting Fee | $21,375 |
|---|---|
| Honoraria | $17,863 |
| Travel and Lodging | $14,511 |
| Food and Beverage | $1,203 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Elekta, Inc. Dec 19, 2025 | Travel and Lodging ELEKTA MEDICAL LINEAR ACCELERATOR · LINAC SOLUTIONS (LINAC) · travel to NEW DELHI, India | $7,657 |
| Novocure Inc. May 15, 2025 | Consulting Fee | $7,125 |
| Elekta, Inc. Dec 19, 2025 | Travel and Lodging ELEKTA MEDICAL LINEAR ACCELERATOR · LINAC SOLUTIONS (LINAC) · travel to NEW DELHI, India | $4,847 |
| Servier Pharmaceuticals LLC Dec 17, 2025 | Consulting Fee | $4,725 |
| Novocure Inc. Nov 6, 2025 | Honoraria | $3,758 |
| Novocure Inc. Dec 4, 2025 | Honoraria Optune Lua (NovoTTF-200T) · Oncology | $3,750 |
| Novocure Inc. Dec 4, 2025 | Consulting Fee Optune Gio; Optune Lua (NovoTTF-200T) · Oncology | $3,375 |
| Novocure Inc. May 23, 2025 | Honoraria Optune Lua (NovoTTF-200T) · Oncology | $3,000 |
| Novocure Inc. Oct 9, 2025 | Honoraria | $2,740 |
| Novocure Inc. Dec 4, 2025 | Honoraria | $2,055 |
All 34 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Gt Medical Technologies, Inc Dec 31, 2025 | Consulting Fee GammaTile · CNS | $500 |
| Gt Medical Technologies, Inc Dec 31, 2025 | Consulting Fee GammaTile · CNS | $250 |
| Gt Medical Technologies, Inc Dec 31, 2025 | Consulting Fee GammaTile · CNS | $250 |
| Novocure Inc. Dec 22, 2025 | Travel and Lodging Optune Gio · Oncology · travel to orlando, FL | $402 |
| Novocure Inc. Dec 22, 2025 | Travel and Lodging Optune Gio · Oncology · travel to orlando, FL | $3.00 |
| Elekta, Inc. Dec 19, 2025 | Travel and Lodging ELEKTA MEDICAL LINEAR ACCELERATOR · LINAC SOLUTIONS (LINAC) · travel to NEW DELHI, India | $7,657 |
| Elekta, Inc. Dec 19, 2025 | Travel and Lodging ELEKTA MEDICAL LINEAR ACCELERATOR · LINAC SOLUTIONS (LINAC) · travel to NEW DELHI, India | $4,847 |
| Novocure Inc. Dec 18, 2025 | Travel and Lodging travel to FORT LAUDERDALE, FL | $68.88 |
| Servier Pharmaceuticals LLC Dec 17, 2025 | Consulting Fee | $4,725 |
| Novocure Inc. Dec 4, 2025 | Honoraria Optune Lua (NovoTTF-200T) · Oncology | $3,750 |
| Novocure Inc. Dec 4, 2025 | Consulting Fee Optune Gio; Optune Lua (NovoTTF-200T) · Oncology | $3,375 |
| Novocure Inc. Dec 4, 2025 | Honoraria | $2,055 |
| Novocure Inc. Dec 4, 2025 | Travel and Lodging Optune Gio; Optune Lua (NovoTTF-200T) · Oncology · travel to SAN FRANCISCO, CA | $52.31 |
| Novocure Inc. Nov 20, 2025 | Honoraria | $685 |
| Novocure Inc. Nov 6, 2025 | Honoraria | $3,758 |
| Gt Medical Technologies, Inc Oct 15, 2025 | Consulting Fee GammaTile · CNS | $600 |
| Gt Medical Technologies, Inc Oct 15, 2025 | Consulting Fee GammaTile · CNS | $600 |
| Novocure Inc. Oct 9, 2025 | Honoraria | $2,740 |
| Novocure Inc. Oct 9, 2025 | Consulting Fee Optune Gio; Optune Lua (NovoTTF-200T) · Oncology | $750 |
| Gt Medical Technologies, Inc Oct 7, 2025 | Consulting Fee GammaTile · CNS | $500 |
| Gt Medical Technologies, Inc Oct 7, 2025 | Consulting Fee GammaTile · CNS | $250 |
| Gt Medical Technologies, Inc Oct 7, 2025 | Consulting Fee GammaTile · CNS | $250 |
| Novocure Inc. Aug 28, 2025 | Honoraria Optune Lua (NovoTTF-200T) · Oncology | $1,875 |
| Novocure Inc. Aug 22, 2025 | Travel and Lodging travel to FLL, FL | $273 |
| Novocure Inc. Aug 22, 2025 | Travel and Lodging travel to FLL, FL | $128 |
| Gt Medical Technologies, Inc Jul 14, 2025 | Consulting Fee GammaTile · CNS | $500 |
| Gt Medical Technologies, Inc Jul 14, 2025 | Consulting Fee GammaTile · CNS | $250 |
| Gt Medical Technologies, Inc Jul 14, 2025 | Consulting Fee GammaTile · CNS | $250 |
| Gt Medical Technologies, Inc Jun 2, 2025 | Consulting Fee GammaTile · CNS | $600 |
| Gt Medical Technologies, Inc Jun 2, 2025 | Consulting Fee GammaTile · CNS | $600 |
| Novocure Inc. May 23, 2025 | Honoraria Optune Lua (NovoTTF-200T) · Oncology | $3,000 |
| Novocure Inc. May 15, 2025 | Consulting Fee | $7,125 |
| Novocure Inc. May 15, 2025 | Travel and Lodging travel to PARIS, France | $145 |
| Gt Medical Technologies, Inc Mar 8, 2025 | Travel and Lodging GammaTile · CNS · travel to Santa Barbara, CA · in-kind | $934 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 7 industry-funded studies in 2025, from 5 companies. The companies reported $225,062 in research payments for these studies, mostly to the institutions running them.
- Characterization of 18F-Fluciclovine PET Amino Acid Radiotracer in Resected Brain Metastasis
Blue Earth Diagnostics · Recruiting · NCT05554302 - 18F-Fluciclovine PET Amino Acid Evaluation of Brain Metastasis Treated With Stereotactic Radiosurgery
Blue Earth Diagnostics · Recruiting · NCT06048094 - EF-24 Pivotal, randomized, open-label study of Tumor Treating Fields (TTFields) concurrent with standard of care therapies for treatment of stage 4 non-small cell lung cancer (NSCLC) following platinum failure.
Novocure Inc. - EF-36 a pilot, randomized, open-label study evaluating the safety and effectiveness of Tumor Treating Fields (TTFields) with pembrolizumab for first-line treatment of advanced or metastatic non-small cell lung cancer …
Novocure GmbH - GTM-101
Gt Medical Technologies, Inc - Assess Use of 18F-Fluciclovine for Patients With Large Brain Metastases Treated With Staged Stereotactic Radiosurgery
Blue Earth Diagnostics · Recruiting · NCT04689048 - Investigator Sponsored Research: A 1537093.002
Medtronic, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.